These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 21120944)
1. Verification of the three-step model in assessing the pathogenicity of mismatch repair gene variants. Kansikas M; Kariola R; Nyström M Hum Mutat; 2011 Jan; 32(1):107-15. PubMed ID: 21120944 [TBL] [Abstract][Full Text] [Related]
2. Assessing how reduced expression levels of the mismatch repair genes MLH1, MSH2, and MSH6 affect repair efficiency. Kansikas M; Kasela M; Kantelinen J; Nyström M Hum Mutat; 2014 Sep; 35(9):1123-7. PubMed ID: 24924810 [TBL] [Abstract][Full Text] [Related]
3. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients. Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297 [TBL] [Abstract][Full Text] [Related]
4. Detection of DNA mismatch repair proteins in fresh human blood lymphocytes--towards a novel method for hereditary non-polyposis colorectal cancer (Lynch syndrome) screening. Hassen S; Boman BM; Ali N; Parker M; Somerman C; Ali-Khan Catts ZJ; Ali AA; Fields JZ J Exp Clin Cancer Res; 2011 Oct; 30(1):100. PubMed ID: 22017758 [TBL] [Abstract][Full Text] [Related]
5. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome. Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989 [TBL] [Abstract][Full Text] [Related]
6. UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families. Grandval P; Fabre AJ; Gaildrat P; Baert-Desurmont S; Buisine MP; Ferrari A; Wang Q; Béroud C; Olschwang S Database (Oxford); 2013; 2013():bat036. PubMed ID: 23729658 [TBL] [Abstract][Full Text] [Related]
7. Clinical characterization and mutation spectrum in Caribbean Hispanic families with Lynch syndrome. Cruz-Correa M; Diaz-Algorri Y; Pérez-Mayoral J; Suleiman-Suleiman W; Gonzalez-Pons Mdel M; Bertrán C; Casellas N; Rodríguez N; Pardo S; Rivera K; Mosquera R; Rodriguez-Quilichini S Fam Cancer; 2015 Sep; 14(3):415-25. PubMed ID: 25782445 [TBL] [Abstract][Full Text] [Related]
8. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Berginc G; Bracko M; Ravnik-Glavac M; Glavac D Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325 [TBL] [Abstract][Full Text] [Related]
9. A putative Lynch syndrome family carrying MSH2 and MSH6 variants of uncertain significance-functional analysis reveals the pathogenic one. Kantelinen J; Hansen TV; Kansikas M; Krogh LN; Korhonen MK; Ollila S; Nyström M; Gerdes AM; Kariola R Fam Cancer; 2011 Sep; 10(3):515-20. PubMed ID: 21431882 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive functional assessment of MLH1 variants of unknown significance. Borràs E; Pineda M; Brieger A; Hinrichsen I; Gómez C; Navarro M; Balmaña J; Ramón y Cajal T; Torres A; Brunet J; Blanco I; Plotz G; Lázaro C; Capellá G Hum Mutat; 2012 Nov; 33(11):1576-88. PubMed ID: 22736432 [TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity. Farrell MP; Hughes DJ; Drost M; Wallace AJ; Cummins RJ; Fletcher TA; Meany MA; Kay EW; de Wind N; Power DG; Andrews EJ; Green AJ; Gallagher DJ Fam Cancer; 2013 Dec; 12(4):741-7. PubMed ID: 23712482 [TBL] [Abstract][Full Text] [Related]
13. Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions. Thompson BA; Greenblatt MS; Vallee MP; Herkert JC; Tessereau C; Young EL; Adzhubey IA; Li B; Bell R; Feng B; Mooney SD; Radivojac P; Sunyaev SR; Frebourg T; Hofstra RM; Sijmons RH; Boucher K; Thomas A; Goldgar DE; Spurdle AB; Tavtigian SV Hum Mutat; 2013 Jan; 34(1):255-65. PubMed ID: 22949387 [TBL] [Abstract][Full Text] [Related]
14. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing]. Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589 [No Abstract] [Full Text] [Related]
15. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419 [TBL] [Abstract][Full Text] [Related]
16. Analysis of mismatch repair gene mutations in Turkish HNPCC patients. Tunca B; Pedroni M; Cecener G; Egeli U; Borsi E; Zorluoglu A; Di Gregorio C; Yilmazlar T; Yerci O; de Leon MP Fam Cancer; 2010 Sep; 9(3):365-76. PubMed ID: 20373145 [TBL] [Abstract][Full Text] [Related]
17. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome. Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ; Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173 [TBL] [Abstract][Full Text] [Related]
18. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines. Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M Tumori; 2014; 100(3):315-20. PubMed ID: 25076244 [TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581 [TBL] [Abstract][Full Text] [Related]
20. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins. Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]